Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Other Countries

Set Alert for Other Countries

Global Medtech Guidance Tracker: August 2023

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Forty-three documents have been posted on the tracker since its last update.

Guidance Documents Regulation

Canada Updates 18-Year-Old Guide On What Constitutes Advertising

Keeping press releases about a product on the manufacturer's website landing page for more than a year may be considered to be promotional, according to Health Canada's update guidance that includes myriad revisions, including a new section on using social media.

Canada Advertising, Marketing & Sales

Supreme Court Decision Makes Partnerships With International Manufacturers More Crucial For US Firms

Supreme Court finds presumption against extraterritorial reach of US laws, saying Congress never “affirmatively and unmistakably instructed” Lanham Act provisions apply to foreign conduct. Contracting with manufacturers abroad is potential pitfall for protecting trademarks, along with licensing brands to foreign marketers.

Consumer Legal Issues

Global Medtech Guidance Tracker: July 2023

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty documents have been posted on the tracker since its last update.

Guidance Documents Regulation

News We’re Watching: Quidel Recall, Partnerships For Teladoc And Lifebit, Alaris Cybersecurity Issues

This week, Quidel recalled the Triage cardiac panel due to a risk of false results; Teladoc and Lifebit announced new partnerships; and, a court upheld a false advertising verdict against Natera, but struck the financial penalties.

Commercial Regulation

Global Medtech Guidance Tracker: June 2023

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Forty-one documents have been posted on the tracker since its last update.

Guidance Documents Regulation

News We’re Watching: New CDC Director, Endologix Study Success, Hospital Closure Linked To Ransomware

This week, North Carolina health secretary Mandy Cohen was named the new head of the CDC; Congress debated PAHPA reauthorization; Cala Health launched a Parkinson’s Disease wearable; and IHealth.io was fined for consumer privacy violations.

Regulation Leadership

Canada Proposes List Of ‘Critical Products’ & More Agile Regulation To Address Shortages

The Canadian government says stakeholders are “poised for action” to improve the collective response to medical product shortages and has come up with some questions and possible answers as to how best to go about it.

Canada Supply Chain

Global Medtech Guidance Tracker: April 2023

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 30 documents have been posted on the tracker since its last update.

Guidance Documents Regulation

English, Canadian and US HTA Bodies Team Up On Unpublished Clinical Data Transparency Drive

NICE, CADTH and ICER say they have taken a step toward greater transparency of unpublished data and a tangible outcome resulting from cooperation among global health technology assessment bodies.

Policy United Kingdom

How Authorities Should Communicate Globally About Device Threats

Only those countries signed up to the International Medical Device Regulators Forum are automatic members of the new global communication system for risky devices and IVDs.

International Europe

Global Medtech Guidance Tracker: March 2023

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Forty-four documents have been posted on the tracker since its last update.

Guidance Documents Regulation

Canada Consults On Policy Changes For Registering Clinical Trials And Disclosing Results

Health Canada is taking steps to improve transparency on authorized clinical trials and is creating a new trials search portal.

Clinical Trials Guidance Documents

Global Medtech Guidance Tracker: February 2023

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Forty-one documents have been posted on the tracker since its last update.

Guidance Documents Regulation

Global Medtech Guidance Tracker: January 2023

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Forty-eight documents have been posted on the tracker since its last update.

Guidance Documents Regulation

International Initiative Tackles Paucity Of Rare Disease Devices

What is the importance of medtech in diagnosing and treating rare diseases? This is among the key questions that an international working group aims to address through a collection of articles in the Orphanet Journal of Rare Diseases.

EU United Kingdom
See All
UsernamePublicRestriction

Register